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Down-regulation of the Wnt/β-catenin signaling 
pathway by Cacnb4
ABSTRACT The β4 isoform of the β-subunits of voltage-gated calcium channel regulates cell 
proliferation and cell cycle progression. Herein we show that coexpression of the β4-subunit 
with actors of the canonical Wnt/β-catenin signaling pathway in a hepatoma cell line inhibits 
Wnt-responsive gene transcription and decreases cell division, in agreement with the role of 
the Wnt pathway in cell proliferation. β4-subunit–mediated inhibition of Wnt signaling is ob-
served in the presence of LiCl, an inhibitor of glycogen synthase kinase (GSK3) that promotes 
β-catenin translocation to the nucleus. Expression of β4-subunit mutants that lost the ability 
to translocate to the nucleus has no effect on Wnt signaling, suggesting that β4-subunit inhibi-
tion of Wnt signaling occurs downstream from GSK3 and requires targeting of β4-subunit to 
the nucleus. β4-subunit coimmunoprecipitates with the TCF4 transcription factor and overex-
pression of TCF4 reverses the effect of β4-subunit on the Wnt pathway. We thus propose that 
the interaction of nuclear β4-subunit with TCF4 prevents β-catenin binding to TCF4 and leads 
to the inhibition of the Wnt-responsive gene transcription. Thereby, our results show that 
β4-subunit is a TCF4 repressor and therefore appears as an interesting candidate for the 
regulation of this pathway in neurons where β4-subunit is specifically expressed.
INTRODUCTION
The voltage-gated calcium channel (VGCC) is a heteromeric protein 
complex found not only at the plasma membrane of most excitable 
cells, but also in nonexcitable cells including lymphocytes (Badou 
et al., 2013). VGCCs are composed of a main pore-forming α1-
subunit generally associated with the auxiliary subunits β, α2δ, and 
γ. Among these, the β-subunits exhibit an important set of functions 
such as the regulation of α1-subunit trafficking to the plasma mem-
brane (Bichet et al., 2000) and of its gating and kinetics properties 
(De Waard and Campbell, 1995). Ca2+ entering the cell through 
VGCC, in response to membrane depolarization, directly or indi-
rectly participates in several organ-specific cellular events including 
muscle contraction, neurotransmitter release, cell division, and gene 
transcription (Deisseroth et al., 2003; Flavell and Greenberg, 2008; 
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sponsive genes. Using a cell line harboring a constitutive level of 
Wnt/β-catenin activity, we show that heterologous expression of 
the β4-subunit induces a strong inhibition of Wnt-responsive gene 
transcription. We show that this effect depends on the nuclear tar-
geting of the β4-subunit and on its interaction with the transcrip-
tion factor of the TCF family. Our results show that the β4-subunit 
acts as a repressor of TCF and competes with β-catenin for the 
binding to TCF.
RESULTS
To study the effect of the VGCC β4-subunit on the Wnt/β-catenin 
pathway, we first generated a human hepatocellular carcinoma 
(HCC) FOCUS cell line, referred to as TCF+, stably expressing a 
reporter gene system under the control of four WREs in tandem. 
FOCUS cells show a constitutive moderate activity of the Wnt/β-
catenin pathway under the control of Wnt3 protein and Frizzled 
7 plasma membrane receptor (FZD7) and do not present any muta-
tion of the different elements of this pathway (Kim et al., 2008). In 
the absence of nuclear β-catenin accumulation, the TCF transcrip-
tion factor binds to the WRE and represses the expression of the 
downstream reporter genes. When the Wnt signaling pathway is 
activated following the binding of Wnt to FZD, β-catenin translo-
cates into the nucleus where it binds to TCF and relieves its 
transcription repressor activity leading to the activation of the 
downstream reporter genes. Two reporter genes were placed under 
the control of TCF encoding for luciferase and copGFP, respectively. 
A FOCUS cell line, referred to as TCF−, expressing the same reporter 
gene system but missing the WRE sequences and thus insensitive to 
the Wnt/β-catenin pathway, was used as control. Finally, a cell line 
was generated that, in addition to the luciferase/copGFP reporter 
gene system, stably expresses both ectopic HA-tagged Wnt3 pro-
tein and V5 tagged FZD7. This cell line is referred to as TCF+/Wnt3+/
FZD7+. The expression of both FZD-V5 and Wnt3-HA in TCF+ and 
TCF+/Wnt3+/FZD7+ cells is illustrated in Figure 1A (right panel). The 
activation of the Wnt/β-catenin pathway in the TCF+/Wnt3+/FZD7+ 
cell line causes the increase of 1) β-catenin concentration (Figure 
1A), 2) luciferase and copGFP fluorescence (Figure 1B), and 3) Cyclin 
D1 and Axin2 mRNA levels (Figure 1C).
β4-Subunit inhibits cell proliferation
In a previous study, we showed that heterologous expression of 
the β4-subunit in CHO cells inhibits cell proliferation (Rima et al., 
2017). We thus investigated the effect of β4-subunit expression on 
the proliferation of TCF+/Wnt3+/FZD7+ cells using the Cell Prolif-
eration Dye eFluor 670. To this end, cells were transfected with 
plasmids coding for β4-eGFP or enhanced green fluorescent pro-
tein (eGFP) as a control. Twenty-four hours later, cells were labeled 
with the dye and the proliferation rate was assessed after 24, 48, 
and 72 h. The results show that the proliferation index of β4-eGFP–
expressing cells was significantly lower than those expressing 
eGFP (after 72 h, proliferation index = 16.2 ± 0.4 and 9 ± 0.2 for 
TCF+/Wnt3+/FZD7+ cells expressing eGFP and β4-eGFP, respec-
tively, p ≤ 0.0001; Figure 2A). An assessment of β4-subunit subcel-
lular distribution in TCF+/Wnt3+/FZD7+ cells shows that β4-eGFP is 
mainly localized in the nucleus and accumulated within the nucle-
oli, whereas eGFP is evenly distributed in the nucleus and in the 
cytosol (Figure 2B).
β4-Subunit regulates the transcriptional activity of the 
TCF promoter
We then investigated the effect of β4-subunit expression on Wnt-
responsive gene expression. To this end, the different cell lines 
Greer and Greenberg, 2008). As a consequence, mutations of any of 
the VGCC subunits that affect Ca2+ current are associated to various 
pathologies (Bidaud et al., 2006). However, during the past decade, 
accumulating evidence has revealed the direct involvement of the 
VGCC β-subunit (herein referred to as β-subunit) as well as of differ-
ent domains of the α1-subunit in processes that take place in cellular 
locations different from the plasma membrane. Although some of 
these functions may still be regulated by Ca2+, they highlight the 
fact that both the β-subunit and α1-subunit domains may act at a 
distance from the Ca2+ channel moiety and thus in a VGCC-inde-
pendent manner.
Indeed, different isoforms of the β-subunit have been shown to 
control the transcription of different genes (Hibino et al., 2003; 
Zhang et al., 2010; Xu et al., 2011; Tadmouri et al., 2012, Ronjat 
et al., 2013). β-Subunits exert this effect by 1) interacting with and 
controlling the activity of various transcription factors including the 
thyroid hormone receptor TRα  (Tadmouri et al., 2012) or Pax6c 
(Zhang et al., 2010) and 2) by recruiting proteins involved in DNA 
remodeling such as the heterochromatin protein 1 (Hibino et al., 
2003; Xu et al., 2011; Tadmouri et al., 2012). The C-terminal do-
main of the pore-forming α1-subunit has been shown to act as a 
transcription factor that controls expression of several genes 
(Gomez-Ospina et al., 2006; Du et al., 2013). In addition, some 
mutations of the β4-subunit and of the C-terminal domain of the 
α1c-subunit associated with human pathologies have been shown 
to affect their role in gene regulation, whereas they only mildly 
modify VGCC gating properties (Escayg et al., 2000; Watase et al., 
2008). In a recent study, we showed that proliferation of CHO cells 
was inhibited by expression of the β4-subunit. This effect required 
nuclear localization of the β4-subunit because the expression of 
β4-subunit mutants defective for the nuclear translocation has no 
effect on cell proliferation (Rima et al., 2017). We thus investigated 
whether the expression of β4-subunit affects the Wnt/β-catenin 
signaling pathway, which is one of the fundamental mechanisms 
that control cell proliferation (for review, see Logan and Nusse, 
2004, and Al-Harthi, 2012). The Wnt signaling pathway plays an 
important role during embryonic and brain development (Logan 
and Nusse, 2004; Mulligan and Cheyette, 2012), particularly in 
synapse formation and remodeling, dendritic growth and arboriza-
tion, neurotransmission, neuroplasticity, neurogenesis, and neuro-
protection (Maguschak and Ressler, 2012). In the absence of Wnt, 
β-catenin phosphorylation by the glycogen synthase kinase 3 
(GSK3) promotes its degradation by the proteasome. Activation of 
the pathway induced by Wnt binding to the membrane receptor 
Frizzled (FZD) inhibits GSK3, resulting in the stabilization of β-
catenin and its translocation to the nucleus where it interacts with 
members of the T-cell factor (TCF)/lymphocyte enhancer factor 
(LEF) transcription factors. β-catenin thus relieves the action of 
TCF/LEF-associated repressors leading to the activation of Wnt-
dependent genes transcription (MacDonald et al., 2009). TCF/LEF 
transcription factors bind to DNA consensus sequences referred to 
as the Wnt-responsive element (WRE) and control the transcription 
of many genes, among which are genes involved in cell prolifera-
tion such as Cyclin D1 (Graham et al., 2000; MacDonald et al., 
2009; Cadigan and Waterman, 2012). Alteration of this pathway is 
associated to many pathologies including cancer and neurological 
diseases (MacDonald et al., 2009; Inestrosa et al., 2012), and a 
continuously increasing number of proteins are implicated in its 
regulation.
In this study, we extend our previous findings highlighting the 
role of the VGCC-β4 subunit on cell proliferation and gene tran-
scription by investigating its effect on the transcription of Wnt-re-
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that do not overexpress Wnt3 and FZD7 
(0.18 ± 0.06 A.U. for β4-eGFP– expressing 
cells compared with 0.28 ± 0.03 A.U. for 
eGFP-expressing cells; p ≤ 0.0001). In con-
trast, no significant change of luciferase ac-
tivity was observed under expression of β4-
subunit in TCF− cells missing the WRE, 
indicating the specificity of the β4-subunit 
inhibition of the Wnt pathway. A similar ef-
fect of β4-subunit expression was observed 
by measuring copGFP transcription (Figure 
3B). In this case, cells were transfected with 
β4-myc encoding cDNA or empty plasmid 
as control and copGFP expression was 
quantified 24 h later. To test the specificity 
of the action of the β4-subunit on the TCF 
promoter in HCC cells, we tested its effect 
on the serum-response factor (SRF)–depen-
dent gene expression. HCC cells were 
transfected with a reporter gene system un-
der the control of serum-response element 
(SRE) together with eGFP or β4-eGFP. Sensi-
tivity of this reporter gene system to the 
activation by SRF is highlighted by the in-
crease of the SRE-luciferase activity when 
cells were incubated for 4 h in the presence 
of serum before measurement (Figure 3C). 
In contrast to what was observed in TCF+/
Wnt3+/FZD7+ cells, expression of β4-eGFP 
did not produce any significant change in 
SRE-luciferase activity either in the absence 
or in the presence of serum. To further con-
firm the inhibitory effect of β4-subunit on 
the activity of the Wnt signaling pathway, 
we measured the endogenous expression 
of two well-known Wnt-responsive genes, 
Cyclin D1 and Axin2 (Shtutman et al., 1999; 
Jho et al., 2002), by quantitative real-time 
PCR (qRT–PCR). As shown in Figure 4A, the 
Cyclin D1 mRNA level measured in TCF+/
Wnt3+/FZD7+ cells significantly decreases in 
the presence of the β4-subunit (1 ± 0.1 and 
0.4 ± 0.1 in cells expressing eGFP and β4-
eGFP, respectively; p ≤ 0.01), whereas tran-
scription of Axin2 is almost totally inhibited 
(1 ± 0.1 and 0.05 ± 0.1 in cells expressing 
eGFP and β4-eGFP, respectively; p ≤ 
0.0001). Together, these observations sug-
gest that the β4-subunit partakes in the 
Wnt/β-catenin signaling pathway leading to 
the repression of the Wnt-responsive genes 
transcription.
β4-Subunit regulates the Wnt pathway downstream from 
GSK3
One of the key steps of the Wnt signaling pathway is the inhibition of 
GSK3 leading to the stabilization of β-catenin. To determine whether 
β4-subunit regulation takes place upstream of or downstream from 
GSK3 inhibition, we measured the effect of the β4-subunit under in-
hibition of GSK3 by LiCl. By inhibiting GSK3 activity, LiCl prevents 
β-catenin degradation and leads to its nuclear accumulation and the 
activation of Wnt-dependent genes, and therefore represents a 
described above were transfected with cDNA coding for β4-eGFP 
or eGFP and luciferase expression was measured 24 h later (Figure 
3A). β4-subunit expression results in a twofold decrease of the lucif-
erase expression in condition of ectopic boosting of the Wnt/β-
catenin pathway, that is, in TCF+/Wnt3+/FZD7+ cells (0.44 ± 0.07 
A.U. for β4-eGFP–expressing cells compared with 0.95 ± 0.08 A.U. 
for eGFP-expressing cells; p ≤ 0.0001). A significant decrease was 
also observed in cells expressing β4-subunit and harboring basal 
steady-state Wnt/β-catenin pathway activation, that is, in TCF+ cells 
FIGURE 1: Characterization of the TCF+/Wnt3+/FZD7+ cell line. (A) Left panel: intracellular 
accumulation of β-catenin in TCF+ and TCF+/Wnt3+/FZD7+ cells. Right panel: expression of 
Wnt3-V5 and FZD7-HA in the TCF+ and TCF+/Wnt3+/FZD7+ cells. Cell lysate and culture medium 
were analyzed by SDS–PAGE and Western blot using anti–β-catenin, anti-V5 (Wnt3-V5), anti-HA 
(FZD7-HA), or anti-actin antibodies. (B) Left panel: increase of copGFP reporter gene expression 
in TCF+/Wnt3+/FZD7+ was measured by flow cytometry. copGFP fluorescence signal measured 
in TCF+/Wnt3+/FZD7+ cells (red), TCF+ cells (blue), and TCF− cells (gray; n = 4). Right panel: 
luciferase activity was measured in TCF+ and TCF+/Wnt3+/FZD7+ cells (n = 4). (C) Cyclin D1 (left 
panel; n = 3) and Axin2 (right panel; n = 9) mRNA expression level measured by RT-PCR in TCF+ 
and TCF+/Wnt3+/FZD7+ cell lines. *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001.
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ability to control gene transcription (Tadmouri et al., 2012; Ronjat 
et al., 2013). This variant (rs1805032) has been identified in a pa-
tient suffering a form of juvenile myoclonic epilepsy (Escayg et al., 
2000) and is reported as a risk factor for the disease by ClinVar. 
Interestingly, although both mutations affect β4-subunit nuclear lo-
calization, the L125P mutation abolishes its interaction with the 
α1-subunit (McGee et al., 2004; Takahashi et al., 2004), whereas 
the R482X mutation only slightly affects the β4-subunit interaction 
with the channel moiety (Escayg et al., 2000). We thus examined 
whether any of these two β4-subunit mutations modify the effect of 
β4-subunit expression on Wnt signaling. As shown in Figure 5A 
(top panel), β1-481-eGFP mutant is defective for nuclear localization 
in TCF+/Wnt3+/FZD7+ cells (compared with β4-eGFP; Figure 2B), 
whereas βL125P-eGFP mutant is entirely excluded from the nucleus. 
Expression of β1-481-eGFP or βL125P-eGFP mutant in TCF+/Wnt3+/
FZD7+ and TCF−/Wnt3+/FZD7+ cells did not affect the luciferase 
reporter gene activity (Figure 5B). These results show that the 
structural integrity of the β4-subunit allowing its nuclear targeting 
is required for its effect on the expression of Wnt-responsive genes 
expression.
β4-Subunit interacts with the TCF4 transcription factor
As mentioned above, the main endpoint regulators of the Wnt 
signaling pathway are the TCF/LEF transcription factors. We thus 
investigated whether the β4-subunit interacts with the TCF4 tran-
scription factor. Using anti-GFP antibodies, we immunoprecipitated 
β4-eGFP expressed in TCF+/Wnt3+/FZD7+ cells. Figure 6A (left 
panel) shows that endogenous TCF4 coprecipitates with β4-eGFP 
demonstrating the presence of a β4-eGFP/TCF4 complex. To test 
the β4/TCF4 interaction in a tissue in which both proteins are en-
dogenously expressed we immunoprecipitated endogenous β4 
from adult mice brain extract. Figure 6A (right panel) shows that 
endogenous TCF4 coimmunoprecipitates with endogenous β4, in-
dicating that β4/TCF4 interaction indeed takes place in mice adult 
brain. Control immunoprecipitation using immunoglobulin G (IgG)-
coated beads instead of anti-eGFP or anti–β4-coated beads shows 
no precipitation of β4-eGFP, β4, or TCF4. Similarly, coimmunopre-
cipitation of the β4-subunit and TCF4 was observed in CHO cells 
expressing both β4-eGFP and TCF4-myc (Figure 6B, left panel). Im-
munoprecipitation with anti-eGFP antibodies in CHO cells express-
ing TCF4-myc and eGFP do not lead to precipitation of TCF4-myc 
(Figure 6B, right panel). In contrast to what is observed with β4-
eGFP, immunoprecipitation of β1-481-eGFP with anti-GFP resulted 
in a very low level of TCF4-myc precipitation, whereas immunopre-
cipitation of βL125P-eGFP did not lead to TCF4-myc precipitation. 
These results indicate that mutations of the β4-subunit that perturb 
its nuclear localization also prevent its interaction with TCF4. Using 
a similar approach, we also investigated the interaction of the β4-
subunit with β-catenin as well as with Kaiso, a member of the BTB/
POZ family of zinc finger transcription factors that has been shown 
to modulate the Wnt/β-catenin pathway (Park et al., 2005). No in-
teraction of the β4-subunit with any of these proteins was observed 
(unpublished data).
Overexpression of TCF4 counteracts β4-subunit inhibitory 
effect of Wnt signaling
Because the β4-subunit interacts with TCF4 but not with β-catenin, 
we hypothesized that the β4-subunit and β-catenin compete for 
their interaction with TCF4. Direct, or indirect, interaction of the β4-
subunit with TCF4 would thus preclude β-catenin/TCF4 interaction 
and consequently the relief of TCF4 repression by TCF4 repressors, 
therefore maintaining the inhibition of Wnt-dependent genes 
strong chemical activator of the Wnt signaling pathway (Klein and 
Melton, 1996). HCC TCF+/Wnt3+/FZD7+ cells transfected with β4-
myc cDNA or with empty plasmid (pcDNA) were treated with LiCl (20 
mM) for 24 h and copGFP expression was quantified at the end of 
the incubation. The results (Figure 4B) show that 1) LiCl induces an 
increase of copGFP expression as compared with NaCl treatment, 
showing the activation of the Wnt pathway and 2) the expression of 
the β4-subunit significantly reduces the level of copGFP expression 
induced by LiCl. This finding suggests that the β4-subunit inhibits the 
Wnt/β-catenin pathway downstream from GSK3, likely within the 
nucleus.
In a previous study, we showed that the structural integrity of 
the β4-subunit is required for its translocation to the nucleus. In-
deed, the β4-subunit L125P mutation that is known to preclude the 
intramolecular interaction between the two globular SH3 and GK 
domains (McGee et al., 2004; Takahashi et al., 2005) completely 
abolishes its translocation to the nucleus (Tadmouri et al., 2012). 
Furthermore, the R482X nonsense mutation found in exon 14 in-
troduces an upstream stop codon that causes the truncation of the 
last C-terminal 38 amino acids (Escayg et al., 2000). The loss of 
these 38 amino acids impairs β4-subunit nuclear localization and its 
FIGURE 2: β4-subunit expression inhibits the proliferation of TCF+/
Wnt3+/FZD7+ cells. (A) Proliferation index of TCF+/Wnt3+/FZD7+ cells 
expressing eGFP (black bars) or β4-eGFP (gray bars). The proliferation 
index was calculated using ModFit LT based on the decrease of Cell 
Proliferation Dye eFluor 670 signal (n = 3). ****, p ≤ 0.0001. 
(B) Representative confocal images of TCF+/Wnt3+/FZD7+ cells 
expressing β4-eGFP or eGFP (green). Nuclei were visualized with 
DAPI (blue).
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FIGURE 3: Effect of β4-subunit on TCF and SRE-dependent 
transcription. (A) Luciferase activity measured in TCF+/Wnt3+/FZD7+, 
TCF+, and TCF− cells expressing eGFP (black bars) or β4-eGFP (gray 
bars). (B) copGFP fluorescence measured in TCF+/Wnt3+/FZD7+, 
TCF+, and TCF− cells expressing pcDNA (black bars) or β4-myc (gray 
bars). Luciferase and copGFP activity were normalized to the value 
measured in TCF+/Wnt3+/FZD7+ cells expressing eGFP (A) or pcDNA 
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with n = 3. **, p ≤ 0.01; ****, p ≤ 0.0001.
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2017). Here, we describe the generation of a cell line stably express-
ing a double reporter gene (luciferase/copGFP) under the control of 
the WRE and TCF4. This cell line was further modified to stably ex-
press Wnt3 and FZD7, giving rise to a cell line exhibiting a constitu-
tively activated canonical Wnt signaling pathway. Another cell line 
was generated that stably expresses the reporter genes but missing 
the WRE sequences, making the reporter genes insensitive to 
TCF4/β-catenin activation and thus to Wnt signaling. Using these 
cell lines we show that expression of β4-subunit inhibits the expres-
sion of Wnt-responsive genes such as Cyclin D1 and Axin2. Cyclin 
D1 was previously identified as playing an important role in cell 
cycle progression (Baldin et al., 1993). β4-Subunit–induced inhibition 
of Cyclin D1 expression could thus participate in the decrease of 
proliferation observed in cells expressing β4-subunit. Axin2 is a 
member of the Wnt-responsive gene family and its expression has 
been proposed to represent a negative feedback loop by favoring 
β-catenin degradation (Jho et al., 2002).
In contrast to what we observed with wild-type β4-subunit, ex-
pression of nuclear targeting deficient β4-subunit mutants does not 
significantly modify β-catenin–mediated gene transcription. This re-
sult suggests that the effect of β4 relies on both its structural integrity 
and nuclear localization. Finally, we demonstrate that β4-subunit in-
teracts with the transcription factor TCF4 and prevents the relief of its 
transcription repressor activity by β-catenin. The most established 
model for canonical Wnt signaling pathway relies on the fact that in 
the absence of Wnt, TCF4 binds to WRE sequences and acts as a 
transcriptional repressor for Wnt-responsive genes. This repressor 
activity is due to the interaction of TCF4 with a number of corepres-
sor proteins that stabilize the transcriptional repression state of TCF4 
(Ishitani et al., 1999). Under activation of the Wnt pathway, β-catenin 
relocates to the nucleus and induces the unhooking of TCF4 core-
pressors allowing the functional remodeling of TCF4 that becomes a 
transcriptional activator. In this study, we show that β4-subunit di-
rectly or indirectly interacts with TCF4 and that its inhibitory effect on 
Wnt-dependent genes transcription can be reversed by exogenous 
TCF4. We also show that the β4-subunit/TCF4 complex also forms in 
the mice adult brain, reinforcing the physiological importance of this 
interaction. We thus propose that by interacting with TCF4, β4-
subunit prevents the recruitment of β-catenin and thus the removal 
of the corepressor proteins from TCF4. Whether the β4-subunit/
TCF4 interaction takes place within the cytoplasm or within the nu-
cleus remains to be established. When TCF4 concentration is in-
creased, a TCF4/β-catenin complex can be formed again leading to 
the activation of Wnt target genes. Our results show that β4-subunit 
maintains TCF4 transcriptional repressor activity pointing to β4-
subunit as a member of the TCF4 corepressor family. The importance 
of the β4-subunit/TCF4 interaction has to be considered in view of 
the high affinity of β-catenin for TCF4 (20 nM) that makes the identi-
fication of potent antagonists of this interaction difficult (Kahn, 2014).
We previously showed that β4-subunit accumulates in the nucleoli. 
It has been recently proposed that the nuclear ratio between β-
catenin and TCF is critical to ensure the optimal efficiency of Wnt 
signaling (Phillips and Kimble, 2009). It is thus also possible that, by 
sequestering TCF4 within the nucleoli, β4-subunit decreases the 
concentration of nuclear TCF4 available for interacting with β-
catenin and thus the concentration of β-catenin/TCF4 complexes. 
On the other hand, β4-subunit interacts with B56δ, a regulatory sub-
unit of PP2A phosphatase (Tadmouri et al., 2012), and the phos-
phorylation/dephosphorylation process is known to control tran-
scription factors activity (Wlodarchak and Xing, 2016). Indeed, the 
Traf2- and NCK-interacting kinase (TNIK) phosphorylates TCF3 
and TCF4 (Shitashige et al., 2010) leading to the activation of their 
transcription. We thus tested whether β4-subunit–induced inhibition 
of Wnt signaling can be reversed by overexpressing TCF4 in TCF+/
Wnt3+/FZD7+ cells expressing β4-subunit. As shown in Figure 7A, 
β4-subunit–dependent inhibition of copGFP expression is prevented 
when TCF4-myc is coexpressed along with β4-subunit. Figure 7B 
shows that β4-subunit expression is not modified by the expression 
of TCF4. Therefore, excess of TCF4 is able to rescue the β-catenin–
dependent transcriptional activity of TCF4, and consequently, to 
ride up copGFP expression to its level measured in the absence of 
β4-subunit. These results further strengthen a model of competitive 
binding of β4-subunit and β-catenin on TCF4.
DISCUSSION
This study follows our previous findings establishing the role of the 
β4-subunit in gene transcription regulation (Tadmouri et al., 2012; 
Ronjat et al., 2013) and its effect on cell proliferation (Rima et al., 
FIGURE 5: β4-Subunit L125P and R482X mutations prevent its 
dependent inhibition of Wnt signaling. (A) Representative confocal 
images of TCF+/Wnt3+/FZD7+ cells expressing β1-481-eGFP (green; 
top panel) or βL125P-eGFP (green; bottom panel). Nuclei were labeled 
with DAPI (blue). (B) Luciferase expression in TCF+/Wnt3+/FZD7+ or 
TCF−/Wnt3+/FZD7+ cells expressing eGFP (black bars), β1-481-eGFP 
(light-gray bars), or βL125P-eGFP (dark-gray bars). Luciferase activity 
was normalized to its value in TCF+/Wnt3+/FZD7+ cells expressing 
eGFP (n = 3).
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with 10% fetal bovine serum, penicillin (100 U/ml), and strepto-
mycin (10 µg/ml).
Generation of focus cell lines stably expressing reporter 
genes under the control of TCF/LEF
The FOCUS (Ozturk et al., 1987) HCC cell lines were maintained in 
DMEM supplemented with 10% fetal calf serum (FCS), 1% sodium 
pyruvate, 1% MEM nonessential amino acids, 1% glutamax, 100 µg/
ml penicillin G, and 100 U/ml streptomycin. FOCUS cells have con-
stitutive moderate activation of the Wnt/β-catenin under the control 
of the Wnt3 and FZD7 components, and absence of any mutations 
in the different elements of the pathway (CTNNB1, AXIN, APC, 
GSK3β; Kim et al., 2008; Yuzugullu et al., 2009). This cell line was 
manipulated in order to overexpress Wnt3 and FZD7 along with a 
TCF/LEF reporter gene. The reporter genes encoding for the Firefly 
luciferase and copGFP, respectively, are under the control of the 
murine cytomegalovirus (mCMV) minimal promoter, and four repeti-
tions of the WRE sequence recognized by the transcription factors 
TCF/LEF are located upstream of the mCMV (TCF+ cells). A plasmid 
lacking the WRE sequences was used as negative control (TCF− 
cells). TCF+ and TCF− cells were transduced in order to stably ex-
press Wnt3 and FZD7 (TCF+/Wnt3+/FZD7+ cells and TCF−/Wnt3+/
FZD7+, respectively).
Plasmids and lentiviral transductions and TCF transcriptional 
activity assay
Human FZD7 cDNA was cloned into the plasmid plenti6/V5 direc-
tional TOPO with blasticidin resistance gene (Invitrogen; Nambotin et 
al., 2011), resulting in a plenti6-FZD7/V5 plasmid encoding for a V5-
tagged FZD7 membrane protein, and empty plenti6/V5 serving as 
negative control. The pUSEamp-WNT3 plasmid (Upstate) was sub-
cloned into pLenti6/V5 directional TOPO plasmid, and thereafter into 
pBB/HA plasmid with hygromycin resistance gene, resulting in a pBB-
WNT3/HA plasmid encoding for an HA-tagged Wnt3 excreted pro-
tein and empty pBB/HA serving as negative control. All constructs 
were verified by sequence analysis of both strands. Virions were pro-
duced in human embryonic kidney (HEK) 293T cells (Invitrogen) and 
hepatoma cells were transduced at a multiplicity of infection of one 
(MOI-1). For the TCF transcriptional activity assay, plasmids PGF1-
TCF/LEF-GFP (TR013PA-P) and PGF1-mCMV negative GFP control 
(TR010PA-P) with puromycin resistance gene (Gentaur) were used to 
produce virions. The corresponding lentiviruses were transduced at 
MOI-10. GFP-expressing cells were monitored by flow cytometry 
(FACSCalibur and CellQuestPro software). Luciferase-expressing cells 
were monitored with the luciferase assay systems E1500 (Promega).
Measure of β-catenin, FZD7, and Wnt3 expression
TCF+ and TCF+/Wnt3+/FZD7+ cells were harvested by scrapping, ho-
mogenized and sonicated in lysis buffer consisting of 30 mM Tris-HCl, 
pH 7.5, 150 mM NaCl, 1% NP40, 0.5% desoxycholate, 0.1% SDS, 
2 mM EDTA, pH 7.5, 10% glycerol, 50 mM NaF, 2 mM Na3VO4, and 
10 µl/ml complete protease inhibitor cocktail. Protein concentration 
was measured with the BCA reagent kit (Pierce). Western blotting was 
carried out using anti–β-catenin 1/500 (Santa Cruz), anti–β-actin 
1/10,000 (Sigma) antibodies, and anti-V5 antibodies 1/5000 (Sigma) 
or anti-HA antibodies (Sigma). After adding the secondary horserad-
ish peroxidase conjugated antibody, blots were visualized with the 
enhanced chemiluminescence detection system (Amersham).
Quantitative real-time RT-PCR (qRT-PCR)
Total RNA was extracted from cultured cells with Extract-all (Euro-
bio), whereas total RNA from FACS-sorted cells was extracted with 
transcriptional activity (Mahmoudi et al., 2009). β4-Subunit, by tar-
geting B56δ/PP2A to TCF4, could thus modify its phosphorylation 
state and as a consequence its effect on transcription.
β-Subunits have been described to interact with and control 
the activity of different transcription factors (Hibino et al., 2003; 
Zhang et al., 2010; Xu et al., 2011; Tadmouri et al., 2012). Our 
results add TCF4 to this list, suggesting that the control of 
transcription factor activity is an intrinsic property of β4-subunit. 
Wnt-responsive genes play a major role in basic cellular events 
such as cell proliferation, and abnormal Wnt signaling has been 
shown to be responsible for a number of pathologies including 
cancers (Polakis, 2012) and neurological diseases (Kalkman, 2012). 
Identification of proteins that control the action of β-catenin there-
fore represents an important milestone in the understanding of the 
tuning mechanisms of the Wnt signaling pathway in normal and 
pathological contexts.
MATERIALS AND METHODS
CHO cell culture
CHO cells were cultured in complete cell culture media contain-
ing DMEM/nutrient mixture F-12 (DMEM/F-12) supplemented 
FIGURE 6: β4-Subunit interacts with the transcription factor TCF4. 
(A) Left panel: coimmunoprecipitation of β4-eGFP and endogenous 
TCF4 by anti-eGFP antibodies in TCF+/Wnt3+/FZD7+ cells. Right 
panel: antibodies directed against β4-subunit immunoprecipitate 
endogenous β4-subunit/TCF4 complex in adult brain mice extract. 
(B) Left panel: coimmuno precipitation of β4-eGFP and TCF4-myc via 
anti-eGFP antibodies in CHO cells. Right panel: lack of 
coimmunoprecipitation shows the absence of TCF4-myc/eGFP 
interaction. (C) Left panel: immunoprecipitation of βL125P does not 
induce precipitation of TCF4-myc. Right panel: β1-481-eGFP 
immunoprecipitation poorly precipitates TCF4-myc. Control IP were 
done using IgG-coated beads.
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Sequences of the different primers designed using the Primer3 
website are as follows: for Axin2, 5′-ATGGTGAGGTCCACGG-
AAAC-3′ and 5′-CTTCACACTGCGATGCATTT-3′; for Cyclin D1, 
5′-AAGGCGGAGGAGACCTGCGCG-3′ and 5′-ATCGTGCGGCA-
TTGCGGC-3′ and for 18s 5′-GGACACGGACAGGATTGACA-3′ and 
5′-ACCCACGGAATCGAGAAAGA-3′.
Cell proliferation measurement
Cells were labeled with 2.5 µM Cell Proliferation Dye eFluor 670 
(eBioscience) for 10 min at 37°C in the dark. The labeling was then 
stopped by adding five volumes of ice-cold complete media and in-
cubating cells on ice for 5 min. At the end of the incubation period, 
cells were washed three times with complete media and analyzed by 
flow cytometry in a BD Accuri C6 system with a 640-nm laser. Various 
amounts of cells were then plated in 12WP to obtain 90% confluence 
after 24, 48, or 72 h of incubation. When the cultured cells reached 
90% confluence, the cells were harvested, resuspended in 
DMEM/F-12 without phenol red, and the dilution of the fluorescent 
dye was assessed by flow cytometry. A minimum of 5000 events were 
analyzed for each sample. Obtained peaks were deconvoluted and 
the proliferation index was calculated using ModFit LT software.
Cell transfection
Expression vectors and cDNA constructs coding for pcDNA, eGFP, 
β4-eGFP (GenBank accession code L02315), β1-481-eGFP, βL125P-
eGFP, B56δ-myc, and β4-myc were previously described (Tadmouri 
et al., 2012). Plasmid coding for TCF4-myc and β-catenin were from 
Mireia Duñach (Universitat Autònoma de Barcelona, Departament 
de Bioquimica I de Biologia Molecular). The reporter construct SRE-
Luc was a generous gift of Vincent Sauzeau (Inserm UMR 1087/
CNRS, Nantes, France). CHO and FOCUS cells were transfected us-
ing Lipofectamine 2000 as per the manufacturer’s instructions.
Luciferase and copGFP reporter assay
Twenty-four hours after transfection, cells were detached and sorted 
based on eGFP fluorescence as described above. An equal number 
of eGFP-positive cells for each condition was collected in 96-well 
plates. Firefly luciferase activity was then quantified with the Dual-Glo 
Luciferase Assay System according to manufacturer’s instructions 
(Promega Corporation) using a PHERAstar FS microplate reader. SRE-
Luc reporter luciferase activity was normalized to the Renilla luciferase 
activity of the cotransfected control vector pTK-RL (Promega).
When copGFP reporter gene expression was measured, cells 
were transfected with DNA coding for β4-myc, TCF4-myc, or pcDNA. 
Twenty-four hours after transfection, the cells were detached and 
analyzed by flow cytometry with a BD Accuri C6 system with a 488-
nm laser. Relative fluorescence values were determined by analyzing 
a minimum of 5000 events for each sample. The data were analyzed 
using FCS express 5 and copGFP fluorescence intensity was ex-
pressed as the mode of the peaks.
Immunoprecipitation
Total proteins were extracted from cultured cells or total mouse 
brain using a lysis buffer consisting of 10 mM Tris (pH 7.5), 1.5 mM 
MgCl2, 10 mM KCl, 0.5% Triton X-100, and protease inhibitor cock-
tail (Roche). Cells or brain were incubated in lysis buffer for 30 min 
on ice followed by sonication.
Before the incubation with the cell or brain extract, the magnetic 
Dynabeads Protein G (10003D, Thermo Fisher Scientific) were cou-
pled with the immunoprecipitating antibody. Beads (50 µl) were 
washed three times with PBS-Tween 0.1%, resuspended in 50 µl 
of the washing buffer, and then incubated for 10 min with 10 µg of 
Nucleospin RNA/XS (Macherey Nagel). M-MLV reverse transcriptase 
(Invitrogen) was used for cDNA synthesis after pretreatment by DN-
Ase-I (Roche). PCRs were performed in the Light Cycler 480 (Roche), 
with a mix of 1X-Quantifast Qiagen SYBR Green, 500 nM each 
primer and 12.5 ng cDNA (equivalent total RNA). The thermal 
cycling conditions comprised an initial step of 5 min at 95°C, 
followed by 40 cycles of 10 s at 95°C and 30 s at 60°C. Experiments 
were performed in triplicate. Each PCR run included standard curves 
and a nontemplate control. Analysis was performed using the com-
parative ∆Ct method, and each gene normalized to the 18S RNA as 
housekeeping gene.
Twenty-four hours after transfection, cells, transfected with the 
plasmid coding for eGFP or β4-eGFP, were detached and sorted 
according to their eGFP fluorescence. eGFP-positive cells (200,000) 
were collected for each condition and their total RNA extracted as 
described above.
FIGURE 7: Heterologous expression of TCF4 rescues Wnt/β-catenin–
dependent gene transcription in the presence of β4-subunit. 
(A) copGFP expression was measured by flow cytometry in TCF+/
Wnt3+/FZD7+ and TCF+ cells expressing eGFP (black bars), β4-myc 
(light-gray bars), TCF4-myc (dark-gray bars), or TCF4-myc together 
with β4-myc (empty bars) (n = 3; *, p ≤ 0.05). (B) Expression of β4-myc 
in the different conditions used in A. Identical volumes of cell extract 
from the different cells used in A were analyzed by SDS–PAGE and 
immunolabeling with antibodies directed against β4-subunit (top 
panel) or GAPDH (bottom panel).
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anti-GFP antibody (11814460001, Roche) or anti β4-subunit anti-
body (Everest Biotech) at room temperature under rotation. Anti-
body-coated beads were then washed twice with PBS-Tween 0.1%. 
Mouse IgG (M5284, Sigma)-coated beads were obtained using the 
same protocol and used as negative control. Protein extracts were 
added to antibodies coated beads and incubated for 30 min at 
room temperature under rotation. At the end of the incubation, the 
beads were rinsed three times with PBS-Tween 0.1% and finally re-
suspended in 15 µl of 5X Laemmli buffer for 10 min and then diluted 
with 60 µl of water. The samples were then heated for 10 min at 
70°C and stored at −20°C.
Immunoprecipitated proteins were separated by SDS–PAGE in a 
10% polyacrylamide resolving gel and then electrotransferred to Im-
mobilon-P PVDF Membrane (Millipore). The membrane was blocked 
in 10% blotting-grade blocker (Bio-Rad) in PBS-Tween 0.1% for 1 h at 
room temperature and then incubated for 3 h with 1:5000 primary 
antibody: rabbit polyclonal anti-GFP (A-11122; Thermo Fisher 
Scientific), rabbit polyclonal anti-myc (ab9106; Abcam), rabbit poly-
clonal anti-TCF4 (ab185736; Abcam), or rabbit polyclonal anti-β4 
(Kiyonaka et al., 2007). After washing with PBS-Tween 0.1%, blots 
were incubated with HRP conjugated anti-rabbit IgG (sc-2004; Santa 
Cruz Biotechnology) or HRP conjugated protein A (ab7456; Abcam) 
at room temperature for 45 min. Immunolabeled proteins were visu-
alized with the ECL detection method (Thermo Fisher Scientific).
Cell labeling
Cells cultured on glass coverslips were incubated with 5 µg/ml 
Hoechst 34580 (Thermo Fisher Scientific) for 5 min, washed with 
PBS, and fixed with 4% paraformaldehyde for 15 min. After being 
washed with PBS, cells were permeabilized with 0.1% Triton X-100. 
eGFP-tagged proteins were directly visualized by GFP fluorescence.
Samples were then mounted in ProLong Gold Antifade (P36931; 
Thermo Fisher Scientific) and images were acquired with a Nikon A1 
Confocal microscope. Merged pictures were obtained by ImageJ-
FiJi software.
Statistics
Student’s two-tailed t test was used to calculate the statistical signifi-
cance of differences between two sets of averaged data; p ≤ 0.05 
was considered statistically significant. Data are presented as mean 
± SEM.
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